Anupam Rasayan India Reports Robust Q2 Revenue Growth, Net Profit Surges 86.6%
Anupam Rasayan India Ltd reported impressive Q2 FY2025-26 results. Consolidated revenue surged 148.8% to ₹7,313.98 crore. Net profit increased by 86.6% to ₹571.52 crore. EBITDA grew 68.9% to ₹1,358.89 crore. However, EBITDA margin contracted to 18.54% from 27.35%. The company raised ₹3,700 crore through preferential allotment, using ₹2,768.98 crore for loan repayment and corporate purposes. Total assets reached ₹56,498.46 crore, with equity base expanding to ₹31,972.88 crore.

*this image is generated using AI for illustrative purposes only.
Anupam Rasayan India Ltd , a leading specialty chemicals company, has reported a strong financial performance for the second quarter of the fiscal year 2025-26. The company's results showcase significant growth in revenue and profitability, despite a contraction in margins.
Revenue Soars
For the quarter ended September 30, 2025, Anupam Rasayan reported a consolidated revenue of ₹7,313.98 crore, marking a substantial increase of 148.8% compared to ₹2,939.62 crore in the same quarter of the previous year. This impressive top-line growth underscores the company's expanding market presence and strong demand for its specialty chemical products.
Profitability Surge
The company's bottom line saw a significant improvement:
- Net profit for Q2 FY2025-26 stood at ₹571.52 crore, up by 86.6% from ₹306.23 crore in Q2 FY2024-25.
- On a half-yearly basis, the net profit reached ₹1,056.10 crore, showing a remarkable growth of 146.6% compared to ₹428.34 crore in the corresponding period of the previous year.
EBITDA Performance
Anupam Rasayan's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for the quarter increased to ₹1,358.89 crore, up from ₹804.05 crore in the same quarter last year, representing a growth of 68.9%.
Margin Pressure
Despite the strong revenue and profit growth, the company experienced some pressure on its margins:
- EBITDA margin for Q2 FY2025-26 contracted to 18.54% from 27.35% in Q2 FY2024-25.
- This margin contraction suggests that while the company has significantly expanded its operations, it may be facing some cost pressures or changes in product mix affecting overall profitability ratios.
Financial Position
As of September 30, 2025, Anupam Rasayan's balance sheet reflects a solid financial position:
- Total assets stood at ₹56,498.46 crore, up from ₹52,688.84 crore as of March 31, 2025.
- The company's equity base expanded to ₹31,972.88 crore, compared to ₹28,503.13 crore at the end of the previous fiscal year.
Capital Allocation
During the quarter, Anupam Rasayan made strategic moves to strengthen its capital structure:
- The company allotted 39,14,886 fully paid-up equity shares at an issue price of ₹945.11 per share through a preferential allotment.
- This move raised approximately ₹3,700 crore, of which ₹2,768.98 crore has been utilized for loan repayment and general corporate purposes.
Looking Ahead
As Anupam Rasayan continues to expand its operations and capitalize on the growing demand for specialty chemicals, managing costs and improving operational efficiency will be key focus areas to enhance profitability margins in the coming quarters.
The company's robust financial performance, coupled with its strategic capital raising, positions it well for future growth in the dynamic specialty chemicals sector.
Historical Stock Returns for Anupam Rasayan
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-5.46% | -4.77% | -3.63% | +32.64% | +47.11% | +102.11% |